ReviewClinical kidney journal2026

PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties.

Rajiv Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.